Surrozen Inc. Common Stock (SRZN)
Stock · NASDAQ · Health Care
$23.45as of 10/16/2026
Price chart
Active signals
SRZN Signal Track Record
How signals performed across all stocks →What SRZN's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 36 | +5.8% | 58% | September 24, 2026 |
| Bollinger Band Breakdown | 23 | +0.6% | 52% | September 8, 2026 |
| Bollinger Band Breakout | 22 | -2.4% | 41% | September 24, 2026 |
| 200-Day Moving Average TouchActive now | 10 | -5.5% | 30% | August 20, 2026 |
| Any 20-session window (baseline) | +0.6% | 51% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About SRZN
Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the eye, intestine, liver, lung, retina, kidney, cochlea, cornea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzl…
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Employees
- 44
- Website
- www.surrozen.com
Fundamentals
- 1-day range
- $23.28$25.09
- Market cap
- $251.25M
- P/E (trailing)
- —
- P/E (forward)
- -5.60
- EPS (trailing)
- $-35.79
- Dividend yield
- —
- Beta
- 0.53
- Avg. volume
- 532.5K
How Surrozen Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 23, 2026 · via SEC EDGAR / Finnhub
Forecasts
5 analyst ratings
Surrozen Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- SRZNSurrozen Inc. Common Stock$23.44▼ 6.50%Market cap $251.25MP/E —$11.39$37.83
- TARAProtara Therapeutics Inc. Common Stock$2.32▼ 3.33%Market cap $230.44MP/E —$2.38$7.82
- LCTXLineage Cell Therapeutics Inc. Common Stock$0.98▼ 1.01%Market cap $281.71MP/E —$0.8823$2.09
- EDITEditas Medicine Inc. Common Stock$2.35▼ 3.69%Market cap $283.93MP/E —$1.66$4.33
- CGENCompugen Ltd. Ordinary Shares$1.96▼ 5.77%Market cap $217.54MP/E 5.59$1.43$3.24
- FATEFate Therapeutics Inc. Common Stock$1.79▼ 7.25%Market cap $290.23MP/E —$0.95$3.23
- SABSSAB Biotherapeutics Inc. Common Stock$2.53▼ 2.32%Market cap $294.39MP/E 17.75$2.1$5.15
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| SRZN Surrozen Inc. Common Stock | $251.25M | — | $23.44 | ▼ 6.50% | $11.39$37.83 |
| TARA Protara Therapeutics Inc. Common Stock | $230.44M | — | $2.32 | ▼ 3.33% | $2.38$7.82 |
| LCTX Lineage Cell Therapeutics Inc. Common Stock | $281.71M | — | $0.98 | ▼ 1.01% | $0.8823$2.09 |
| EDIT Editas Medicine Inc. Common Stock | $283.93M | — | $2.35 | ▼ 3.69% | $1.66$4.33 |
| CGEN Compugen Ltd. Ordinary Shares | $217.54M | 5.59 | $1.96 | ▼ 5.77% | $1.43$3.24 |
| FATE Fate Therapeutics Inc. Common Stock | $290.23M | — | $1.79 | ▼ 7.25% | $0.95$3.23 |
| SABS SAB Biotherapeutics Inc. Common Stock | $294.39M | 17.75 | $2.53 | ▼ 2.32% | $2.1$5.15 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Surrozen secures FDA clearance for SZN-8141 clinical trialYahoo · 10/5/2026
- Surrozen Says FDA Cleared IND For SZN-8141 In Diabetic Macular Edema, Triggering About $95.1M Second Tranche Of Private Placementbenzinga · 10/2/2026
- Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular EdemaYahoo · 10/2/2026
- Unusual volume stocks are being observed in Friday's session.ChartMill · 9/25/2026
- Scholastic Posts Downbeat Q1 Results, Joins Legacy Education, Zscaler And Other Big Stocks Moving Lower In Friday’s Pre-Market SessionBenzinga · 9/25/2026
- HC Wainwright & Co. Maintains Buy on Surrozen, Raises Price Target to $54Benzinga · 9/25/2026
- Why INLIF Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving PremarketBenzinga · 9/25/2026
- Keep an eye on the top gainers and losers in Thursday's session.ChartMill · 9/24/2026
- Which stocks are moving on Thursday?ChartMill · 9/24/2026
Insider Activity
Insider Actions →- TCG Crossover GP II, LLC · July 22, 2026 · Sale162.5K @ $21.25
- Andrew Pedrum Maleki · June 15, 2026 · Grant607 @ $19.01
- Yang Li · June 15, 2026 · Grant1.7K @ $8.11
- Craig C. Parker · June 15, 2026 · Grant1.6K @ $8.11
- Charles O. Williams · June 15, 2026 · Grant1.7K @ $8.11
- Tim Kutzkey · May 13, 2026 · Grant5.5K
- Haak-Frendscho Mary · May 13, 2026 · Grant5.5K
- CHAI CHRISTOPHER Y · May 13, 2026 · Grant5.5K
- Eric Bjerkholt · May 13, 2026 · Grant5.5K
- Rothenberg Mace · May 13, 2026 · Grant5.5K
- Berkenblit Anna · May 13, 2026 · Grant5.5K
- WOODHOUSE DAVID J · May 13, 2026 · Grant5.5K
- Yang Li · May 4, 2026 · Sale1.6K @ $33.33
- Craig C. Parker · May 4, 2026 · Sale4.5K @ $33.33
- Charles O. Williams · May 4, 2026 · Sale2.0K @ $33.33
Institutional Ownership
March 31, 2026
- Total shares held
- 8.89M
- Total value held
- $256.21M
- Institutional holders
- 55
- Unknown1.47M
- Unknown766.3K
- Unknown731.1K
- Unknown632.9K
- Unknown525.6K
- Unknown432.0K
- Unknown396.1K
- Unknown387.5K
- Unknown385.2K
- Unknown338.6K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Surrozen Inc. (SRZN) Sees Unusual Volume and Analyst Target Increase
On Friday, SRZN was among the stocks with a volume spike, as noted by ChartMill. The stock also appeared in the list of top gainers and losers in the Thursday session, reflecting a gapping move. Analysts from HC Wainwright & Co. raised their price target to $54, up from the previous average of $48.40. SRZN trades near the upper end of its 52‑week range, with an RSI of 78.1 indicating a high level of buying activity.
Surrozen Inc. (SRZN) Sees Unusual Volume and Analyst Target Increase. On Friday, SRZN was among the stocks with a volume spike, as noted by ChartMill. The stock also appeared in the list of top gainers and losers in the Thursday session, reflecting a gapping move. Analysts from HC Wainwright & Co. raised their price target to $54, up from the previous average of $48.40. SRZN trades near the upper end of its 52‑week range, with an RSI of 78.1 indicating a high level of buying activity.